These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10988199)

  • 1. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.
    Houghton JL; Pearson TA; Reed RG; Torosoff MT; Henches NL; Kuhner PA; Philbin EF
    Chest; 2000 Sep; 118(3):756-60. PubMed ID: 10988199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
    Egashira K; Hirooka Y; Kai H; Sugimachi M; Suzuki S; Inou T; Takeshita A
    Circulation; 1994 Jun; 89(6):2519-24. PubMed ID: 8205659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
    Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholesterol-lowering therapy on endothelial function.
    Houghton JL
    Circulation; 2001 Jul; 104(2):E6. PubMed ID: 11447096
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease.
    Vita JA; Yeung AC; Winniford M; Hodgson JM; Treasure CB; Klein JL; Werns S; Kern M; Plotkin D; Shih WJ; Mitchel Y; Ganz P
    Circulation; 2000 Aug; 102(8):846-51. PubMed ID: 10952951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improvement of endothelial function in patients with hypercholesterolemia and normal coronary arteries with lipid-lowering therapy].
    Iràculis E; Cequier A ; Sabaté M; Pintó X; Antoni Gómez-Hospital J; Mauri J; García Del Blanco B; Fernández-Nofrerias E; Palom X; Jara F; Esplugas E
    Rev Esp Cardiol; 2001 Jun; 54(6):685-92. PubMed ID: 11412774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia.
    Grigore L; Raselli S; Garlaschelli K; Redaelli L; Norata GD; Pirillo A; Catapano AL
    Eur J Clin Pharmacol; 2013 Mar; 69(3):341-6. PubMed ID: 22777149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries.
    Hamasaki S; Higano ST; Suwaidi JA; Nishimura RA; Miyauchi K; Holmes DR; Lerman A
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):737-43. PubMed ID: 10712399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
    Leung WH; Lau CP; Wong CK
    Lancet; 1993 Jun; 341(8859):1496-500. PubMed ID: 8099379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired endothelium-dependent vasodilation of coronary resistance vessels in hypercholesterolemic patients.
    Shiode N; Kato M; Hiraoka A; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1996 Feb; 35(2):89-93. PubMed ID: 8680111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension.
    Houghton JL; Davison CA; Kuhner PA; Torossov MT; Strogatz DS; Carr AA
    J Am Coll Cardiol; 1998 Feb; 31(2):374-82. PubMed ID: 9462582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients.
    Baldassarre D; Busnach G; Amato M; Pazzucconi F; Sirtori CR
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):108-17. PubMed ID: 10464783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
    Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
    J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.
    Seiler C; Suter TM; Hess OM
    J Am Coll Cardiol; 1995 Dec; 26(7):1615-22. PubMed ID: 7594094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
    Lee IT; Lee WJ; Ou HC; Huang CN; Sheu WH
    Metabolism; 2009 Mar; 58(3):416-20. PubMed ID: 19217460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.